Given that the expression of HSF1 and its target genes participating in HSR is increased in USP7i-resistant cancer cells, we hypothesized that the USP7i-induced phosphorylation and activation of HSF1 lead to resistance to USP7i-based chemotherapy. The gene discussed is HSF1; the disease is cancer.